WPRIM Management System> DCMS> Blood Research> 2021> 56> 4

Volume: 56 Issue: 4

1. Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma Page:349—353
2. Real-life ruxolitinib experience in intermediate-risk myelofibrosis Page:322—331
3. Blood management strategies in congenital Glanzmann thrombasthenia at a hematology referral center Page:315—321
4. Immune thrombocytopenic purpura worsened by COVID-19 Page:347—349
5. Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999‒2018 Page:301—314
6. The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19 Page:293—300
7. Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan Page:279—284
8. Mutation analysis and characterisation of F9 gene in haemophilia- B population of India Page:252—258
9. Effects and treatment applications of polymeric nanoparticles on improving plateletsÊ storage time: a review of the literature from 2010 to 2020 Page:215—228
10. R-MPV followed by high-dose chemotherapy with thiotepa-based and autologous stem cell transplantation for newly diagnosed primary central nervous system lymphoma: a single-center experience Page:285—292
11. Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis Page:266—278
12. Clinical features and outcomes of JAK2V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2V617F allele burden Page:259—265
13. Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea Page:243—251
14. Subclinical thrombotic thrombocytopenic purpura after vaccination with ChAdOx1nCoV-19 Page:212—214
15. Therapy-related acute myeloid leukemia in a patient with B-cell acute lymphoblastic leukemia Page:339—342
16. Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia Page:332—333
17. A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities Page:229—242
18. Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy Page:209—211
19. A case of e1a2 (minor, P190) BCR-ABL1-positive chronic myeloid leukemia in Korea Page:345—347
20. Efficacy of ponatinib prior to and after allogeneic hematopoietic stem cell transplantation in an adolescent with chronic myeloid leukemia in blast phase Page:342—345
21. A look inside the body of a BCR-ABL1−like acute lymphoblastic leukemia patient: the first case report highlighting the continued relevance of autopsy practice Page:335—339
22. Tp53 disruptions: is there a marker of poor prognosis in chronic lymphoproliferative disorders? Page:333—334

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.